Shares of the genetic testing company have more than doubled in less than a week. It likely isn't durable.

DNA-sequencing leader Illumina swung to a loss in Q2 2022. Contributions from Grail didn't help.

The formerly high-flying growth stock is stalling against macroeconomic headwinds. How quickly can the business get back on track?

This lab-hardware business is growing, cashed up, and close to profitability.

On Wednesday, Ark snapped up shares of Twilio, Roblox, Coinbase and JD.com. It sold Twitter and Palantir Technologies.

Invitae says a $1.15 billion investment from a Softbank-led group will support the medical-genetics company's growth opportunities.

Pacific Biosciences says Softbank's $900 million investment 'validates our leadership position in the long-read DNA sequencing market.'

Jim Cramer says young investors may have unorthodox investing ideas, but their strategies are working. Here's what they're buying.

U.S. stock futures sink and oil prices surge after a U.S. military strike kills Gen. Qassem Soleimani, a top Iranian general; the U.S. economic calendar includes the ISM Manufacturing Index for December and minutes from the Federal Reserve’s Dec. 10-11 meeting; Illumina abandons $1.2 billion acquisition of Pacific Biosciences.

U.S. retirees may get a big benefit with the next Social Security cost-of-living adjustment for 2023.

Core retail sales improved firmly in July, but the headline figure was essentially unchanged as gas prices tumbled from their June record highs.

E-commerce giant Amazon is the subject of a major investigation linked to its Prime service. It's not sitting idly by.